DE102006033167A1 - Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers - Google Patents
Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers Download PDFInfo
- Publication number
- DE102006033167A1 DE102006033167A1 DE102006033167A DE102006033167A DE102006033167A1 DE 102006033167 A1 DE102006033167 A1 DE 102006033167A1 DE 102006033167 A DE102006033167 A DE 102006033167A DE 102006033167 A DE102006033167 A DE 102006033167A DE 102006033167 A1 DE102006033167 A1 DE 102006033167A1
- Authority
- DE
- Germany
- Prior art keywords
- gelatin
- use according
- solution
- gel
- crosslinking agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920000159 gelatin Polymers 0.000 title claims abstract description 300
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 300
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 290
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 290
- 239000008273 gelatin Substances 0.000 title claims abstract description 280
- 239000003431 cross linking reagent Substances 0.000 title claims abstract description 69
- 238000004132 cross linking Methods 0.000 title claims abstract description 66
- 230000001070 adhesive effect Effects 0.000 title claims description 94
- 239000000853 adhesive Substances 0.000 title claims description 88
- 238000002360 preparation method Methods 0.000 title claims description 18
- 239000000499 gel Substances 0.000 claims abstract description 141
- 239000003292 glue Substances 0.000 claims abstract description 29
- 241001465754 Metazoa Species 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 84
- 108060008539 Transglutaminase Proteins 0.000 claims description 62
- 102000003601 transglutaminase Human genes 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 230000015572 biosynthetic process Effects 0.000 claims description 21
- 239000008247 solid mixture Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 18
- 239000007943 implant Substances 0.000 claims description 15
- 230000000740 bleeding effect Effects 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 239000004971 Cross linker Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 241000251468 Actinopterygii Species 0.000 claims description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 9
- 239000002158 endotoxin Substances 0.000 claims description 9
- 238000009997 thermal pre-treatment Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000004033 plastic Substances 0.000 claims description 8
- 229920003023 plastic Polymers 0.000 claims description 8
- 210000000056 organ Anatomy 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 239000012876 carrier material Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000000536 complexating effect Effects 0.000 claims description 3
- 238000012454 limulus amebocyte lysate test Methods 0.000 claims description 3
- 230000035515 penetration Effects 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 230000014509 gene expression Effects 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 150000003949 imides Chemical class 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 24
- 238000001879 gelation Methods 0.000 description 19
- 230000008901 benefit Effects 0.000 description 15
- 238000013459 approach Methods 0.000 description 14
- 208000032843 Hemorrhage Diseases 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000001828 Gelatine Substances 0.000 description 10
- 239000011550 stock solution Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 102000008946 Fibrinogen Human genes 0.000 description 8
- 108010049003 Fibrinogen Proteins 0.000 description 8
- 108090000190 Thrombin Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 229940012952 fibrinogen Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 229960004072 thrombin Drugs 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 235000015277 pork Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 240000005702 Galium aparine Species 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 108010039627 Aprotinin Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108010071289 Factor XIII Proteins 0.000 description 2
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 229960004405 aprotinin Drugs 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000006855 networking Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- 229960003766 thrombin (human) Drugs 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101100210287 Drosophila melanogaster wech gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 108010058237 plasma protein fraction Proteins 0.000 description 1
- 229940081857 plasma protein fraction Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/104—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006033167A DE102006033167A1 (de) | 2006-07-10 | 2006-07-10 | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers |
| AT07785971T ATE525098T1 (de) | 2006-07-10 | 2007-07-10 | Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers |
| ES07785971T ES2370095T3 (es) | 2006-07-10 | 2007-07-10 | Uso de gelatina y transglutaminasa para la preparación de un adhesivo médico reticulable. |
| PCT/EP2007/006105 WO2008006545A2 (de) | 2006-07-10 | 2007-07-10 | Verwendung von gelatine und einem vernetzungsmittel zur herstellung eines vernetzenden medizinischen klebers |
| JP2009518780A JP5204103B2 (ja) | 2006-07-10 | 2007-07-10 | 架橋医療用膠剤を製造するためのゼラチンおよび架橋剤の使用 |
| EP07785971A EP2037972B1 (de) | 2006-07-10 | 2007-07-10 | Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers |
| US12/350,320 US9295751B2 (en) | 2006-07-10 | 2009-01-08 | Use of gelatin and a cross-linking agent for producing cross-linking medical glues |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006033167A DE102006033167A1 (de) | 2006-07-10 | 2006-07-10 | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102006033167A1 true DE102006033167A1 (de) | 2008-01-24 |
Family
ID=38596783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102006033167A Withdrawn DE102006033167A1 (de) | 2006-07-10 | 2006-07-10 | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9295751B2 (enExample) |
| EP (1) | EP2037972B1 (enExample) |
| JP (1) | JP5204103B2 (enExample) |
| AT (1) | ATE525098T1 (enExample) |
| DE (1) | DE102006033167A1 (enExample) |
| ES (1) | ES2370095T3 (enExample) |
| WO (1) | WO2008006545A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006033168A1 (de) * | 2006-07-10 | 2008-01-17 | Gelita Ag | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung |
| US8133484B2 (en) | 2006-12-15 | 2012-03-13 | Lifebond Ltd | Hemostatic materials and dressing |
| CN103933606B (zh) | 2006-12-15 | 2016-08-24 | 生命连结有限公司 | 明胶-转谷氨酰胺酶止血敷料和密封材料 |
| WO2009153748A2 (en) * | 2008-06-18 | 2009-12-23 | Lifebond Ltd | Methods and devices for use with sealants |
| CA2728187C (en) | 2008-06-18 | 2014-04-29 | Lifebond Ltd | Improved cross-linked compositions |
| US20110104280A1 (en) * | 2009-05-20 | 2011-05-05 | Olexander Hnojewyj | Wound treatment systems, devices, and methods using biocompatible synthetic hydrogel compositions |
| JP5711738B2 (ja) | 2009-07-21 | 2015-05-07 | マローネ バイオ イノベーションズ，インコーポレイテッド | 植物有害生物を防除するためのサルメンチンおよびその類似体の使用 |
| AU2010334412B2 (en) | 2009-12-22 | 2016-02-04 | Lifebond Ltd | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
| CA2807012A1 (en) | 2010-08-05 | 2012-02-09 | Lifebond Ltd. | Dry composition wound dressings and adhesives |
| JP2012095769A (ja) * | 2010-10-29 | 2012-05-24 | Gunze Ltd | 医療用接着剤及び医療用材料 |
| US20130224712A1 (en) * | 2012-02-24 | 2013-08-29 | Bradford L. Day | Medical training kits and methods to simulate treatment of uncontrolled hemorrhage |
| WO2014112208A1 (ja) * | 2013-01-18 | 2014-07-24 | 独立行政法人物質・材料研究機構 | 組織接着剤及びその製造方法 |
| GB2515749B (en) * | 2013-07-01 | 2016-08-31 | Biodynamic Armor Ltd | Pressure impulse mitigation |
| US10814032B2 (en) * | 2014-08-08 | 2020-10-27 | The Brigham And Women's Hospital, Inc. | Elastic biopolymer and use as a tissue adhesive |
| WO2016149615A1 (en) | 2015-03-19 | 2016-09-22 | The Brigham And Women's Hospital, Inc. | Polypeptide compositions and methods of using the same |
| WO2017139318A1 (en) | 2016-02-08 | 2017-08-17 | The Brigham And Women's Hospital, Inc. | Bioadhesive for corneal repair |
| US11679177B2 (en) | 2017-08-08 | 2023-06-20 | Baxter International Inc. | Polymeric compositions, delivery devices, and methods |
| US10738175B2 (en) * | 2017-08-15 | 2020-08-11 | Sanford, L.P. | Glue slime activator and associated methods and kits |
| CN110997781A (zh) * | 2017-08-15 | 2020-04-10 | 桑福德有限合伙人公司 | 胶水史莱姆活化剂及相关方法和试剂盒 |
| CN111432830A (zh) * | 2017-09-29 | 2020-07-17 | 巴德香农有限公司 | 用于从组织的受控药物释放的组合物和方法 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| US12121630B2 (en) | 2018-09-04 | 2024-10-22 | Massachusetts Eye And Ear Infirmary | Light activated adhesive scaffold |
| CN110917389B (zh) * | 2018-09-20 | 2022-03-22 | 广州迈普再生医学科技股份有限公司 | 一种组织封闭组合物、组织封堵胶及其制备方法 |
| EP3904377B1 (en) * | 2018-12-26 | 2023-08-02 | National Institute for Materials Science | Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder |
| CN112245411B (zh) * | 2020-10-16 | 2023-06-16 | 中山大学附属口腔医院 | 一种普适性口腔绷带及其制备方法 |
| CN112646205A (zh) * | 2020-12-10 | 2021-04-13 | 南昌大学 | 一种增强鱼皮明胶凝胶强度的方法 |
| CN115068666B (zh) * | 2021-03-10 | 2023-12-26 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种防粘连的止血水凝胶及其制备方法和应用 |
| WO2024154679A1 (ja) * | 2023-01-16 | 2024-07-25 | 株式会社大塚製薬工場 | 癒着防止材 |
| CN117122729A (zh) * | 2023-08-31 | 2023-11-28 | 太原理工大学 | 一种组织粘附性水凝胶的制备方法及其应用 |
| WO2025069742A1 (ja) * | 2023-09-28 | 2025-04-03 | 大日精化工業株式会社 | 生分解性接着剤組成物、及び生分解性接着剤組成物キット |
| CN119345119B (zh) * | 2024-12-25 | 2025-04-08 | 四川大学华西医院 | 多功能水凝胶、载药水凝胶及其制备方法和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69517714T2 (de) * | 1994-01-24 | 2000-11-23 | Imedex Biomateriaux, Chaponost | Klebstoffzusammensetzung für chirurgische Zwecke enthaltend nichtvernetztes und durch oxidativen Abbau modifiziertes Kollagen |
| DE69432300T2 (de) * | 1993-06-03 | 2004-02-12 | Orthogene, Inc., San Francisco | Biologische klebstoffzusammensetzung und verfahren zum fördern der haftung zwischen flächengewebe |
| JP2004283371A (ja) * | 2003-03-20 | 2004-10-14 | Nagoya Industrial Science Research Inst | 医用材料 |
| DE69630990T2 (de) * | 1995-06-07 | 2004-12-30 | Cohesion Technologies, Inc., Palo Alto | Biovertragliche Klebmasse |
| DE60020330T2 (de) * | 1999-07-21 | 2005-11-03 | Imedex Biomateriaux | Eiweissschaum klebstoff zur chirurgischen und/oder therapeutischen verwendung |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581020A (en) * | 1983-07-18 | 1986-04-08 | Trimedyne, Inc. | Medication delivery device and system for percutaneous administration of medication |
| JPS61152247A (ja) | 1984-12-26 | 1986-07-10 | Ajinomoto Co Inc | 蛋白質膜の製造法 |
| US5385606A (en) | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
| US5939385A (en) | 1993-08-13 | 1999-08-17 | Zymogenetics, Inc. | Transglutaminase cross-linkable polypeptides and methods relating thereto |
| US5428014A (en) | 1993-08-13 | 1995-06-27 | Zymogenetics, Inc. | Transglutaminase cross-linkable polypeptides and methods relating thereto |
| CN1056973C (zh) | 1993-10-04 | 2000-10-04 | 毛里齐奥·托内蒂 | 促进组织愈合和再生的药物组合物及包含其的施用药盒 |
| AU1287895A (en) | 1994-10-03 | 1996-04-26 | Otogen Corporation | Differentially biodegradable biomedical implants |
| FR2726571B1 (fr) * | 1994-11-03 | 1997-08-08 | Izoret Georges | Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique |
| DE19508192A1 (de) * | 1995-03-09 | 1996-09-12 | Behringwerke Ag | Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung |
| US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
| US6565842B1 (en) | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
| US5589322A (en) * | 1995-12-12 | 1996-12-31 | Eastman Kodak Company | Process for making a direct dispersion of a photographically useful material |
| WO1997029715A1 (en) * | 1996-02-20 | 1997-08-21 | Fusion Medical Technologies, Inc. | Compositions and methods for sealing tissue and preventing post-surgical adhesions |
| ATE439849T1 (de) | 1996-04-19 | 2009-09-15 | Osiris Therapeutics Inc | Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen |
| US5834232A (en) | 1996-05-01 | 1998-11-10 | Zymogenetics, Inc. | Cross-linked gelatin gels and methods of making them |
| US6039901A (en) | 1997-01-31 | 2000-03-21 | Givaudan Roure Flavors Corporation | Enzymatically protein encapsulating oil particles by complex coacervation |
| US20020098222A1 (en) | 1997-03-13 | 2002-07-25 | John F. Wironen | Bone paste |
| DE19732917C1 (de) | 1997-07-30 | 1998-10-15 | Fuchsbauer Hans Lothar | Verfahren zum Transglutaminase-katalysierten Koppeln von Protein oder Peptid an einen Träger |
| US20020076429A1 (en) | 1998-01-28 | 2002-06-20 | John F. Wironen | Bone paste subjected to irradiative and thermal treatment |
| US20040036054A1 (en) * | 1998-06-29 | 2004-02-26 | Haslim Leonard Arthur | Environmentally friendly compositions having antiicing, deicing or graffiti prevention properties |
| US20020015724A1 (en) * | 1998-08-10 | 2002-02-07 | Chunlin Yang | Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| ATE324831T1 (de) | 1998-08-26 | 2006-06-15 | Neomend Inc | Kit zur in-situ-erzeugung chemisch verbundener mechanischer barrieren oder abdeckstrukturen für eine punktionsstelle in einem blutgefäss |
| US20030095993A1 (en) * | 2000-01-28 | 2003-05-22 | Hanne Bentz | Gel-infused sponges for tissue repair and augmentation |
| DE60125973D1 (de) | 2000-11-15 | 2007-02-22 | Biosyntech Canada Inc | Verfahren zur wiederherstellung einer geschädigten bandscheibe |
| PL362606A1 (en) * | 2000-11-28 | 2004-11-02 | Wyeth | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| US6685626B2 (en) * | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
| US8182527B2 (en) * | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
| DE10152407A1 (de) | 2001-10-24 | 2003-05-08 | Aesculap Ag & Co Kg | Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten |
| SE0200010D0 (sv) * | 2002-01-02 | 2002-01-02 | Amersham Biosciences Ab | A method of producing hierarchical porous beads |
| JP4624678B2 (ja) | 2002-02-21 | 2011-02-02 | パイオニア・サージカル・オーソバイオロジックス，インコーポレイテッド | 架橋生物活性ヒドロゲルマトリックス |
| WO2004029096A2 (en) * | 2002-09-26 | 2004-04-08 | University Of Maryland Biotechnology Institute | Polysaccharide-based polymers and methods of making the same |
| AU2004268013B2 (en) | 2003-08-29 | 2011-05-12 | Mayo Foundation For Medical Education And Research | Hydrogel porogens for fabricating biodegradable scaffolds |
| US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| US9241902B2 (en) * | 2003-12-17 | 2016-01-26 | R.P. Scherer Technologies, Llc | Chewable soft capsules containing ungelatinized starch |
| DE102004024635A1 (de) * | 2004-05-12 | 2005-12-08 | Deutsche Gelatine-Fabriken Stoess Ag | Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine |
| WO2005115494A2 (en) | 2004-05-27 | 2005-12-08 | Humanitas Mirasole S.P.A. | Use of fibrin for separating body organs |
| WO2006059984A1 (en) | 2004-11-30 | 2006-06-08 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
| US7837986B2 (en) * | 2004-12-01 | 2010-11-23 | E. I. Du Pont De Nemours And Company | Protein-based polymer tissue adhesives for medical use |
| DE102005054938A1 (de) | 2005-11-17 | 2007-05-24 | Gelita Ag | Formkörper auf Basis eines vernetzten, Gelatine enthaltenden Materials, Verfahren zu deren Herstellung sowie deren Verwendung |
| CN101378663A (zh) * | 2005-12-21 | 2009-03-04 | Wm.雷格利Jr.公司 | 包衣的耐嚼糖果产品和方法 |
| DE102006033168A1 (de) * | 2006-07-10 | 2008-01-17 | Gelita Ag | Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung |
| US20110034385A1 (en) * | 2008-04-07 | 2011-02-10 | National Institute Of Immunology | Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder |
-
2006
- 2006-07-10 DE DE102006033167A patent/DE102006033167A1/de not_active Withdrawn
-
2007
- 2007-07-10 EP EP07785971A patent/EP2037972B1/de active Active
- 2007-07-10 AT AT07785971T patent/ATE525098T1/de active
- 2007-07-10 ES ES07785971T patent/ES2370095T3/es active Active
- 2007-07-10 JP JP2009518780A patent/JP5204103B2/ja active Active
- 2007-07-10 WO PCT/EP2007/006105 patent/WO2008006545A2/de not_active Ceased
-
2009
- 2009-01-08 US US12/350,320 patent/US9295751B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69432300T2 (de) * | 1993-06-03 | 2004-02-12 | Orthogene, Inc., San Francisco | Biologische klebstoffzusammensetzung und verfahren zum fördern der haftung zwischen flächengewebe |
| DE69517714T2 (de) * | 1994-01-24 | 2000-11-23 | Imedex Biomateriaux, Chaponost | Klebstoffzusammensetzung für chirurgische Zwecke enthaltend nichtvernetztes und durch oxidativen Abbau modifiziertes Kollagen |
| DE69630990T2 (de) * | 1995-06-07 | 2004-12-30 | Cohesion Technologies, Inc., Palo Alto | Biovertragliche Klebmasse |
| DE60020330T2 (de) * | 1999-07-21 | 2005-11-03 | Imedex Biomateriaux | Eiweissschaum klebstoff zur chirurgischen und/oder therapeutischen verwendung |
| JP2004283371A (ja) * | 2003-03-20 | 2004-10-14 | Nagoya Industrial Science Research Inst | 医用材料 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2037972A2 (de) | 2009-03-25 |
| JP2009542384A (ja) | 2009-12-03 |
| EP2037972B1 (de) | 2011-09-21 |
| ATE525098T1 (de) | 2011-10-15 |
| US9295751B2 (en) | 2016-03-29 |
| JP5204103B2 (ja) | 2013-06-05 |
| US20090175946A1 (en) | 2009-07-09 |
| WO2008006545A3 (de) | 2008-12-04 |
| WO2008006545A2 (de) | 2008-01-17 |
| WO2008006545A8 (de) | 2009-01-29 |
| ES2370095T3 (es) | 2011-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2037972B1 (de) | Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers | |
| DE68918155T2 (de) | Chirurgisches Klebstoffmaterial. | |
| DE69534759T2 (de) | Polyanionische Polysaccharide und hydrophobe, bioabsorbierbare Polymere enthaltende Zusammensetzungen | |
| DE69227705T2 (de) | Verwendung von vernetztem kollagen zur herstellung einer nähfähigen bioverträglichen langsam resorbierbaren membran | |
| DE69333947T2 (de) | Heteromorphe Schwämme mit Wirkstoffen | |
| DE69530711T2 (de) | Verwendung von kollagenmembranen als prothese für peritoneale regeneration | |
| EP1948260B8 (de) | Verbundmaterial, insbesondere für die medizinische anwendung, und verfahren zu dessen herstellung | |
| DE69906321T2 (de) | Zusammensetzungen von kollagengeweben | |
| DE69817574T2 (de) | Herstellungsmethode für ein faserfreies, poröses material | |
| EP2037974B1 (de) | Verwendung von gelatine und einem vernetzungsmittel zur herstellung einer vernetzenden therapeutischen zusammensetzung | |
| AT412445B (de) | Flüssiges collagen-hämostatikum | |
| EP2143771B1 (de) | Klebstoffzusammensetzung, insbesondere zur verwendung in der chirurgischen medizin | |
| DE10152407A1 (de) | Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten | |
| DE19620117C1 (de) | Verfahren zur Herstellung eines calciumsulfathaltigen medizinischen Präparats und calciumsulfathaltiges medizinisches Präparat | |
| EP2812037B1 (de) | Biodegradierbares vlies für medizinische zwecke | |
| EP2185207B1 (de) | Kombination zum verkleben von biologischen geweben | |
| EP2018880B1 (de) | Flächiges Implantat | |
| EP2098255B1 (de) | Verfahren zur Herstellung von Kollagen-material | |
| EP1948257B1 (de) | Formkörper auf basis eines vernetzten, gelatine enthaltenden materials, verfahren zu deren herstellung sowie deren verwendung | |
| DE69302262T2 (de) | Kollagenmikrokapseln enthaltende injezierbare zusammensetzung | |
| WO2009024280A2 (de) | Kollagenhaltiger zellträger | |
| CN115887741B (zh) | 一种可吸收骨蜡及其制备方法 | |
| TWI697335B (zh) | 藥物載體組合、藥物組合物、其用途、其製備方法及其使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| R120 | Application withdrawn or ip right abandoned |
Effective date: 20120801 |